Watch for Aurora shareholder tender response ahead of the December 4 expiry and the Alberta Securities Commission ruling on Curaleaf's application to halt Aurora's ATM program. A favorable regulatory ruling could remove a key defensive tactic and accelerate tender momentum. Monitor for any competing bid or white knight emergence given the hostile nature of the offer.
Price Chart
Executive Summary
Curaleaf Holdings has filed a Notice of Variation, Change and Extension to its unsolicited offer to acquire Aurora Cannabis, increasing the total implied consideration by 25% to US$5.00 per Aurora share (US$1.00 cash + 0.4013 Curaleaf shares), raising the Cap Price to US$6.00, and extending the expiry to December 4, 2026. The enhanced offer represents an 86% premium to Aurora's unaffected 30-day VWAP and includes pro forma financial statements showing a combined entity with >US$1.5B LTM revenue and ~US$350M LTM Adjusted EBITDA. Aurora's board continues to recommend rejection, and Curaleaf has filed an application with the Alberta Securities Commission to halt Aurora's ATM share issuances.
Key Financial Metrics
Key Facts
- Total implied consideration increased 25% to US$5.00 per Aurora share (US$1.00 cash + 0.4013 Curaleaf shares), up from original US$4.00
- Cash consideration increased 33% from US$0.75 to US$1.00 per share; Cap Price increased 20% from US$5.00 to US$6.00
- Offer represents 86% premium to Aurora's 30-day VWAP of US$2.75 on August 10, 2026 (Unaffected Date); 217% premium on ex-cash basis
- Expiry extended to 11:59 p.m. (Mountain Time) on December 4, 2026
- Pro forma combined entity: >US$1.5B LTM revenue, ~US$350M LTM Adjusted EBITDA, at least US$40M expected annual cost synergies, pro forma market cap >US$3B
- Aurora board has recommended shareholders reject the offer; Curaleaf filed application with Alberta Securities Commission to halt Aurora's ATM program
- Total purchase consideration estimated at US$328.7M (100% scenario), funded by US$66.9M cash and issuance of 26.8M Curaleaf shares
- Pro forma combined net loss of US$256M for FY2025; pro forma net income of US$62.9M for H1 2026 (benefiting from one-time tax benefits)
Financial Impact
Total deal value of approximately US$328.7 million (100% scenario), with Curaleaf issuing ~26.8 million shares and paying ~US$66.9 million in cash. Pro forma combined entity would have >US$1.5 billion in LTM revenue and ~US$350 million in LTM Adjusted EBITDA.
Risk Factors
- Aurora board continues to oppose the offer and has recommended rejection; shareholder tender may fall short of the 66 2/3% condition
- Curaleaf's share price decline could reduce the implied value of the stock consideration and trigger the Cap Price mechanism, lowering the exchange ratio
- Regulatory approvals required; cannabis cross-border regulatory complexity could delay or block the transaction
- Aurora's ongoing ATM program dilutes existing shareholders and increases the cost and difficulty of achieving tender thresholds
- Pro forma financials show combined net losses in FY2025; synergy realization is uncertain and not guaranteed
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001104659-26-113908 |
| Document: tm2623363d19_ex99-2.htm | 0001104659-26-113908 |
| Document: tm2623363d19_425.htm | 0001104659-26-113908 |
| Document: 0001104659-26-113908-index-headers.html | 0001104659-26-113908 |
| Document: 0001104659-26-113908-index.html | 0001104659-26-113908 |
| Document: 0001104659-26-113908.txt | 0001104659-26-113908 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 425 / 8-K | $7.86 $8.12 | ▲ +3.30% | ▲ +2.77% | $8.56 (+8.91%) |
Oct 6, 2026 21d ago | 425 | $9.99 $9.85 | ▼ −1.40% | ▼ −1.16% | $8.56 (−14.31%) |
Oct 6, 2026 21d ago | 8-K | $9.99 $9.85 | ▼ −1.40% | ▼ −1.16% | $8.56 (−14.31%) |
Oct 6, 2026 21d ago | 425 | $9.99 $9.85 | ▼ −1.40% | ▼ −1.16% | $8.56 (−14.31%) |
Oct 6, 2026 21d ago | 8-K | $9.99 $9.85 | ▼ −1.40% | ▼ −1.16% | $8.56 (−14.31%) |
Oct 1, 2026 25d ago | 8-K | $9.95 $9.76 | ▼ −1.91% | ▼ −2.58% | $8.56 (−13.97%) |
Oct 1, 2026 25d ago | 8-K | $9.95 $9.76 | ▼ −1.91% | ▼ −2.58% | $8.56 (−13.97%) |
Sep 16, 2026 5w ago | 8-K | $9.98 $10.26 | ▲ +2.81% | ▲ +1.67% | $8.56 (−14.23%) |
Sep 16, 2026 5w ago | 425 | $9.98 $10.26 | ▲ +2.81% | ▲ +1.67% | $8.56 (−14.23%) |
Sep 15, 2026 6w ago | 425 / 8-K | $10.12 $10.13 | ▲ +0.10% | ▼ −0.23% | $8.56 (−15.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers